GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $250,000 | -11.7% | 6,800 | -9.6% | 0.02% | -23.1% |
Q3 2020 | $283,000 | -11.3% | 7,523 | -3.8% | 0.03% | -10.3% |
Q2 2020 | $319,000 | -66.1% | 7,823 | -68.5% | 0.03% | -81.2% |
Q1 2020 | $941,000 | +77.5% | 24,823 | +120.2% | 0.15% | +81.2% |
Q4 2019 | $530,000 | -53.3% | 11,273 | -57.7% | 0.08% | -49.4% |
Q3 2019 | $1,136,000 | 0.0% | 26,623 | -6.2% | 0.17% | 0.0% |
Q2 2019 | $1,136,000 | -15.3% | 28,394 | -11.5% | 0.17% | -7.7% |
Q1 2019 | $1,341,000 | +18.8% | 32,090 | +8.6% | 0.18% | +6.4% |
Q4 2018 | $1,129,000 | -1.1% | 29,541 | +3.9% | 0.17% | +56.9% |
Q3 2018 | $1,142,000 | +0.6% | 28,433 | +0.9% | 0.11% | -32.7% |
Q2 2018 | $1,135,000 | +430.4% | 28,168 | +406.6% | 0.16% | +362.9% |
Q4 2016 | $214,000 | -18.0% | 5,560 | -8.2% | 0.04% | -12.5% |
Q3 2016 | $261,000 | +19.2% | 6,057 | +11.4% | 0.04% | +14.3% |
Q4 2015 | $219,000 | +7.9% | 5,436 | +2.8% | 0.04% | +9.4% |
Q3 2015 | $203,000 | – | 5,286 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |